← Back to patent-cliff list
CAS 1217656-59-1
tert-butyl (R)-piperidin-3-ylcarbamate hydrochloride
Codes：ALOG-020
Application context (from source-drug indications)
二型糖尿病苯甲酸阿格列汀糖尿病苯甲酸阿格列汀急性冠脉综合征苯甲酸阿格列汀
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 苯甲酸阿格列汀Alogliptin Benzoate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-(aminomethyl)benzonitrile→1-(2-cyanobenzyl)-3-methylurea→2-cyanoacetic acid→2-cyano-N-((2-cyanobenzyl)carbamoyl)-N-methylacetamide→2-((6-amino-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile→tert-butyl (R)-piperidin-3-ylcarbamate hydrochloride→tert-butyl (R)-(1-(3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)carbamate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.